Disclosure 0001789617-26-000004-5

SEC FORM 4

$1,716,379.11

Travere Therapeutics, Inc. (TVTX)

Sale of 27,421 shares at $62.5936 per share.

Reporting Person Heerma Peter · Officer Title EVP, CHIEF COMMERCIAL OFFICER · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001789617-26-000004 · filed 2026-09-17 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Travere Therapeutics, Inc. (TVTX)." Disclosed 2026-09-17. https://desqlong.com/cards/0001789617-26-000004-5 (retrieved 2026-09-26).